Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RCVS further extends remote prescribing guidance
The new temporary guidance includes additional safeguards concerning the physical examination of animals.
Updated guidance contains additional safeguards concerning physical examination.

Temporary guidance that currently allows veterinary surgeons to remotely prescribe prescription-only veterinary medicines (POM-Vs) has been extended to 1 November 2020 with additional safeguards.

The new motion, laid out at a recent meeting of RCVS Council, states that remote prescribing 'should only be carried out by veterinary surgeons who can provide a 24/7 follow-up service involving physical examination, plus or minus further investigation if required'.

It also states that such a follow-up service ‘can be provided personally by the veterinary surgeon or practice, or by written agreement with a veterinary services provider which is local to the client (as with the current situation for [out-of-hours] care provision)’.

Temporary guidance on remote prescribing was originally introduced in March in response to the Government's lockdown and social distancing restrictions. Since then, the guidance had been extended several times to reflect the changing circumstances and government guidance surrounding the pandemic.

On Thursday (8 October), a review of the temporary guidance took place at the request of RCVS Council. Council considered all of the evidence considered by the COVID-19 Taskforce, including an independent survey of veterinary practices into their experiences of remote consulting and feedback from different veterinary service providers.

After further discussion, Council voted to support the guidance but with additional safeguards concerning the physical examination of animals and the availability of follow-up care. The decision will be communicated to the profession as soon as possible and effective from 1 November 2020, to allow time for practices to make any necessary adaptations.

Council also agreed that the temporary derogation from the usual requirement to conduct a physical examination before an animal is regarded as ‘under care’ be reviewed as a standing item at each subsequent Standards Committee meeting until normal guidance provisions are restored.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.